HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,417-1,428 of 1,811
Drug study icon
CompletedNCT02293655

The Effects of ADHD Medication (TEAM) Study

Official study title

The Effects of ADHD Medication (TEAM) Study: Neurobehavioral Effects of Abrupt Methylphenidate Discontinuation

This study has finished and is no longer accepting participants.

Multiple locations, including Cincinnati
ADHDMedication studyAges 7–11
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Drug study icon
CompletedNCT02139124

PRC-063 for ADHD

What is this study about?

Researchers compared PRC-063 25 mg, placebo, PRC-063 45 mg, PRC-063 70 mg and PRC-063 100 mg, tracking side effects to assess safety in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Los Angeles
ADHDMedication studyAges 18+
Countries
United States, Canada
Sponsor
Rhodes Pharmaceuticals, L.P.
Behavioral study icon
CompletedNCT04270812

Treating Sleep in Teens With ADHD

Official study title

Treating Sleep Problems in Adolescents With ADHD: A Pilot Study

This study has finished and is no longer accepting participants.

In Cincinnati
ADHDBehavioural studyAges 13–17
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Device study icon
Active Not RecruitingNCT06189703

tRNS Treatment for ADHD Symptoms

This study is no longer accepting new participants.

Multiple locations, including Boston
ADHDDevice studyAges 7–12
Countries
United States, Israel
Sponsor
Innosphere
Drug study icon
CompletedNCT03103750

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD

Official study title

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Study of Stimulant-induced Dopamine Release Using [11C]-PHNO PET in Healthy Humans

This study has finished and is no longer accepting participants.

In New Haven
ADHDMedication studyAges 18–50
Countries
United States
Sponsor
Yale University
Drug study icon
TerminatedNCT04386811

Stimulant-induced Improvement for ADHD

Official study title

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.

This study ended early.

In New Haven
ADHDMedication studyAges 18–50
Countries
United States
Sponsor
Yale University
Drug study icon
Not recruitingEUCTR 2011-005452-34

A Phase 4, Randomised, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 Compared with OROS-MPH with a Placebo Referance Arm, ...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
ADHDHistorical research record
Countries
Germany, Hungary, Italy, + 1 other
Sponsor
Shire Development LLC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.